Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-29
Closed -$613 871
2020
Q3
$544 Sell
29
-114,682
-100% -$2.01M ﹤0.01% 669
2020
Q2
$1.75M Buy
114,711
+42,311
+58% +$730K 0.47% 69
2020
Q1
$1.37M Sell
72,400
-23,922
-25% -$760K 0.38% 63
2019
Q4
$3.54M Sell
96,322
-16,004
-14% -$560K 0.66% 48
2019
Q3
$3.36M Buy
112,326
+11,364
+11% +$356K 0.6% 47
2019
Q2
$3.57M Sell
100,962
-18,934
-16% -$632K 0.63% 45
2019
Q1
$3.83M Buy
+119,896
New +$3.38M 0.76% 37

Other funds holding XRX

Exane Derivatives's XRX Position: Q4 2020 in Review

Exane Derivatives sold out of Xerox (XRX) in Q4 2020, closing a stake of 29 shares — an estimated $613 sold.

Exane Derivatives first reported a position in XRX in Q1 2019 and held it in 7 quarters. The position peaked at $3.83M in Q1 2019. 407 funds tracked by Wall St. Rank hold XRX as of Q4 2020.

  • Exane Derivatives reported no remaining Xerox position as of Q4 2020 after selling out during the quarter.
  • Exane Derivatives sold 29 Xerox shares in Q4 2020, an estimated $613.
  • Exane Derivatives first reported a position in Xerox in Q1 2019 and held it in 7 quarters.
  • Exane Derivatives's Xerox position peaked at $3.83M in Q1 2019.
  • 407 funds tracked by Wall St. Rank held Xerox as of Q4 2020.

Based on Exane Derivatives's 13F filing for Q4 2020, filed 27 Jan 2021.